Recombinant Human TREML2 (C-Fc)

Description

EnkiLife provides the Recombinant Human TREML2 (C-Fc) protein,aslo know as Trem-like transcript 2 protein,TLT2,Triggering receptor expressed on myeloid cells-like protein 2,TLT2,C6orf76, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Triggering Receptor Expressed on Myeloid Cells-like Protein 2 is produced by our Mammalian expression system and the target gene encoding Gly19-Ser268 is expressed with a human IgG1 Fc tag at the C-terminus.Accession:AAI25079.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:54.2 KDa. Background:Trem-like transcript 2 protein (TLT2), also known as Triggering receptor expressed on myeloid cells-like protein 2, TLT2 and C6orf76, is single-pass type I membrane protein. TREML2 contains one Ig-like V-type domain, which can be induced in CD4 T-cell by concanavalin-A. As a cell surface receptor, TREML2 may play a role in the innate and adaptive immune response. TREML2 also acts as a counter-receptor for CD276 and interaction with CD276 on T-cells enhances T-cell activation. It has shown that TREML2 may be involved in the innate immune response based on its expression profile and the fact that it is up-regulated in response to inflammation.